跳至主要内容
临床试验/ACTRN12623000413628
ACTRN12623000413628招募中Unknown

COmparison of carcinoembryonic antigen levels between Portal and PERipheral blood in patients with appendiceal or right sided colon cancer (The COPPER Trial)

Professor David Morris0 个研究点目标入组 15 人开始时间: 2023年4月26日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • *Age range: 18 years and above
  • *Disease status: Appendiceal or right sided colon cancer (suspected or confirmed)
  • *Willingness to give written informed consent and willingness to participate to and comply with the study.
  • * Pre-operative carcino-embryonic antigen (CEA) level > 5 microg/

排除标准

  • *Participants who cannot provide informed consent.
  • *Patients who have had a previous peritonectomy (including those who have previously undergone a right hemicolectomy).

研究者

发起方
Professor David Morris

相似试验